5CUH image
Entry Detail
PDB ID:
5CUH
Keywords:
Title:
Crystal structure MMP-9 complexes with a constrained hydroxamate based inhibitor LT4
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2015-07-24
Release Date:
2016-02-10
Method Details:
Experimental Method:
Resolution:
1.83 Å
R-Value Free:
0.21
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Matrix metalloproteinase-9,Matrix metalloproteinase-9
Chain IDs:A, B
Chain Length:164
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.
Eur.J.Med.Chem. 111 193 201 (2016)
PMID: 26871660 DOI: 10.1016/j.ejmech.2016.01.053

Abstact

Hodgkin's lymphoma (HL) is the most common malignant lymphoma in young adults in the western world. This disease is characterized by an overexpression of ADAM-10 with increased release of NKG2D ligands, involved in an impaired immune response against tumor cells. We designed and synthesized two new ADAM-10 selective inhibitors, 2 and 3 based on previously published ADAM-17 selective inhibitor 1. The most promising compound was the thiazolidine derivative 3, with nanomolar activity for ADAM-10, high selectivity over ADAM-17 and MMPs and good efficacy in reducing the shedding of NKG2D ligands (MIC-B and ULBP3) in three different HL cell lines at non-toxic doses. Molecular modeling studies were used to drive the design and X-ray crystallography studies were carried out to explain the selectivity of 3 for ADAM-10 over MMPs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures